INTRODUCTION
The competencies required in the domain to implement processes to prevent and manage drug interactions, adverse drug reactions and drug resistance are:
5.1 |
Understand the importance of drug interactions, e.g. drug/drug and drug/disease; |
5.2 |
Demonstrate in-depth knowledge of various ART drug interactions and reactions; |
5.3 |
Prevent adverse drug interactions and reactions; and |
5.4 |
Define the types and consequences of drug resistance. |
DOMAIN 5: IMPLEMENT PROCESSES TO PREVENT AND MANAGE DRUG INTERACTIONS, ADVERSE DRUG REACTIONS AND DRUG RESISTANCE
|
COMPETENCIES
|
BEHAVIOURAL STATEMENTS
|
5.1 |
Understand the importance of drug interactions, e.g. drug/drug and drug/disease |
|
5.1.1 |
Understanding the basics of drug interactions. |
5.1.2 |
Listing and describing the consequences of drug interactions. |
Range: therapeutic failure, drug resistance, life-threatening toxicities, poor adherence, increased costs.
5.1.3 |
Demonstrating knowledge and understanding of how the body processes drugs and of specified pharmacological concepts. |
Range: pharmacokinetics and pharmacodynamics, therapeutic index, substrate, inhibitor, inducer.
|
5.2 |
Demonstrate in-depth knowledge of various ART drug interactions and reactions |
|
5.2.1 |
Listing the ARVs most involved in drug interactions. |
5.2.2 |
Describing medicines that may interact with ART and understand their mode of interaction and the management of interaction. |
|
5.3 |
Prevent adverse drug interactions and reactions |
|
5.3.1 |
Knowing how to prevent drug interactions. |
Range: Comprehensive patient questioning and accessing useful resources.
|
5.4 |
Define the types and consequences of drug resistance |
|
5.4.1 |
Demonstrating an understanding of the consequences of drug resistance. |
5.4.2 |
Demonstrating an understanding of the mechanism of HIV drug resistance. |
5.4.3 |
Defining acquired drug resistance, transmitted drug resistance, and pre-treatment drug resistance in patients. |
|